Not finding it? Sign in to also search OpenAlex live.
-
343 Identification of tumor-reactive T cells targeting melanoma Dark Antigens™ validates this novel class of targets for development of immunotherapies2022 Regular and Young Investigator Award Abstracts conference-abstract Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 2 patents
Tom Hofland, Thomas Morgan Hulen, Elizabeth Verdegaal, Joseph D. Dukes, Shawez Khan, Pita de Kok, +9 more
1citations -
P038 Microbial regulation of T-cell fate towards regulatory profiles during T-cell transfer induced colitis2021 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Andrés Machicote, Penelope Pelczar, B Liu, Lydia Kopplin, Manuela Wende, Daniela Indenbirken, +3 more
0citations -
35 Chemokine-driven spatial organization of immune cell microaggregates marks oropharyngeal squamous cell carcinomas containing tumor-specific T cells2021 Regular and Young Investigator Award Abstracts conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Ziena Abdulrahman, Saskia J A M Santegoets, Gregor Sturm, Pornpimol Charoentong, Marieke E. Ijsselsteijn, Antonios Somarakis, +8 more
0citations -
High complete response rates, low dropout rate, and low-grade toxicities in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) receiving GLPG5101, a fresh, early memory-enriched CAR T-cell therapy with a 7-day vein-to-vein time: Results from the ATALANTA-1 DLBCL cohort
Joost S.P. Vermaat, Pim G. N. J. Mutsaers, Sébastien Anguille, Maria Theresa Kuipers, Évelyne Willems, Tim J. A. Dekker, +14 more
2citations -
Poor Outcome of Patients with COVID-19 after CAR T-Cell Therapy for B-Cell Malignancies: Results from a Multicenter Study on Behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
Anne Mea Spanjaart, Per T Ljungman, Rafael de la Cámara, Gloria Tridello, Valentín Ortiz‐Maldonado, Álvaro Urbano-Ispizúa, +28 more
16citations -
148 Primary or iPSC-derived cell-based cytotoxicity assays to assess potential safety risks of engineered T cell therapies in vitro2021 Regular and Young Investigator Award Abstracts conference-abstract Medicine CAR-T cell therapy research Open access
Sophie Vermond, Monique Hazenoot, Rene J. McLaughlin, Sabrina de Munnik, Marco Guadagnoli, Gemma Moiset, +2 more
0citations -
High complete response rates and minimal residual disease (MRD) negativity, with durable responses, in high-risk mantle cell lymphoma (MCL) with GLPG5101, a fresh, early memory-enriched CAR T-cell therapy with a 7-day vein-to-vein time: Results from the ATALANTA-1 MCL cohort
Marie José Kersten, Joost S.P. Vermaat, Pim G. N. J. Mutsaers, Maria Theresa Kuipers, Évelyne Willems, Sébastien Anguille, +14 more
3citations -
Euplagia-1: A Phase 1/2 Trial of GLPG5201, a Fresh Stem-like Early Memory CD19 CAR T-Cell Therapy with a 7-Day Vein-to-Vein Time, in Patients with Relapsed/Refractory CLL and RT
Valentín Ortiz‐Maldonado, Núria Martínez‐Cibrián, Letícia Alserawan, Sergi Betriu, Ana Triguero, Sandra Blum, +8 more
5citations -
Phase 1b study of AMG 757, a half-life extended bispecific T-cell engager (HLE BiTEimmune-oncology therapy) targeting DLL3, in de novo or treatment emergent neuroendocrine prostate cancer (NEPC).2021 Journal of Clinical Oncology conference-abstract Medicine Prostate Cancer Treatment and Research
Rahul Raj Aggarwal, Ana Maria Aparicio, Axel Heidenreich, Shahneen Kaur Sandhu, Yiran Zhang, Mark Salvati, +1 more
14citations -
Abstract S05-01: Profound CD8 T-cell responses towards SARS-CoV-2 OFR1ab in COVID-19 patients2020 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology vaccines and immunoinformatics approaches
Anastasia Gangaev, Steven L. C. Ketelaars, Sanne Patiwael, Anna Dopler, Olga I. Isaeva, Kelly Hoefakker, +13 more
1citations -
770 Personalized synthetic polyepitope DNA cancer vaccines encoding a novel pyroptotic adjuvant to generate effective anti-tumor T cell immunity2021 Regular and Young Investigator Award Abstracts conference-abstract Immunology and Microbiology Immunotherapy and Immune Responses Open access
Jeroen van Bergen, Tsolère Arakelian, Kedar Moharana, Bram Teunisse, Iris Zoutendijk, Marcel G M Camps, +3 more
0citations